EVASENSE Trademark

Trademark Overview


On Saturday, June 19, 2010, a trademark application was filed for EVASENSE with the United States Patent and Trademark Office. The USPTO has given the EVASENSE trademark a serial number of 79087257. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Friday, June 19, 2020. This trademark is owned by Affymax Pharma Limited. The EVASENSE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals for use in stimulating human blood cell production; pharmaceuticals for the treatment of cancer, anemia, ischemia, myocardial infarction, congestive heart failure, renal failure, anoxia-induced cellular degeneration, hypoxia-induced cellular degeneration and stroke
evasense

General Information


Serial Number79087257
Word MarkEVASENSE
Filing DateSaturday, June 19, 2010
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateFriday, June 19, 2020
Registration Number3922323
Registration DateTuesday, February 22, 2011
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 7, 2010

Trademark Statements


Goods and ServicesPharmaceuticals for use in stimulating human blood cell production; pharmaceuticals for the treatment of cancer, anemia, ischemia, myocardial infarction, congestive heart failure, renal failure, anoxia-induced cellular degeneration, hypoxia-induced cellular degeneration and stroke
Pseudo MarkEVA SENSE

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, September 29, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAffymax Pharma Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressLondon EC2A 2RS
GB

Party NameAffymax Pharma Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressLondon EC2A 2RS
GB

Party NameAffymax Pharma Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressLondon EC2A 2RS
GB

Trademark Events


Event DateEvent Description
Saturday, July 10, 2021NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Saturday, July 10, 2021DEATH OF INTERNATIONAL REGISTRATION
Friday, September 14, 2018TOTAL INVALIDATION PROCESSED BY THE IB
Thursday, June 7, 2018TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Thursday, June 7, 2018INVALIDATION PROCESSED
Tuesday, May 29, 2018TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, September 29, 2017CANCELLED SECTION 71
Thursday, August 4, 2016NEW REPRESENTATIVE AT IB RECEIVED
Monday, February 22, 2016COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Friday, October 11, 2013TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, June 3, 2011NOTIFICATION PROCESSED BY IB
Wednesday, April 27, 2011FINAL DISPOSITION NOTICE SENT TO IB
Wednesday, April 27, 2011FINAL DISPOSITION PROCESSED
Thursday, March 24, 2011GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Tuesday, February 22, 2011REGISTERED-PRINCIPAL REGISTER
Tuesday, December 7, 2010PUBLISHED FOR OPPOSITION
Thursday, December 2, 2010ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, December 2, 2010TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, November 17, 2010NOTICE OF PUBLICATION
Wednesday, November 3, 2010LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, November 3, 2010ASSIGNED TO LIE
Wednesday, October 20, 2010APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, October 19, 2010APPLICATION FILING RECEIPT MAILED
Friday, October 15, 2010ASSIGNED TO EXAMINER
Friday, October 15, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, October 14, 2010SN ASSIGNED FOR SECT 66A APPL FROM IB